Anti-NMDAR2B antibody [EPR19295]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(16 Publications )
- WB
Supplier Data
Western blot - Anti-NMDAR2B antibody [EPR19295] (AB183942)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1,2,3,4,5,6 and 7 : 30 seconds; Lane 8 and 9 : 8 seconds.
The expression profile observed is consistent with what has been described in the literature (PMID : 9252405; PMID : 15470155).
All lanes:
Western blot - Anti-NMDAR2B antibody [EPR19295] (ab183942) at 1/1000 dilution
Lane 1:
Human hippocampus lysate at 20 µg
Lane 2:
Human fetal liver lysate at 20 µg
Lane 3:
SH-SY5Y (Human neuroblastoma cell line from bone marrow) whole cell lysate at 20 µg
Lane 4:
Mouse liver lysate at 20 µg
Lane 5:
Mouse kidney lysate at 20 µg
Lane 6:
NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 20 µg
Lane 7:
Neuro-2a (Mouse neuroblastoma cell line) whole cell lysate at 20 µg
Lane 8:
Mouse brain lysate at 20 µg
Lane 9:
Mouse hippocampus lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 166 kDa
Observed band size: 166 kDa
false
- WB
Supplier Data
Western blot - Anti-NMDAR2B antibody [EPR19295] (AB183942)
Blocking/Dilution buffer : 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID : 9252405; PMID : 15470155).
All lanes:
Western blot - Anti-NMDAR2B antibody [EPR19295] (ab183942) at 1/5000 dilution
Lane 1:
Rat brain lysate at 20 µg
Lane 2:
Rat hippocampus lysate at 20 µg
Lane 3:
Rat liver lysate at 20 µg
Lane 4:
C6 (Rat glial tumor cell line) whole cell lysate at 20 µg
Lane 5:
PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 166 kDa
Observed band size: 166 kDa
false
Exposure time: 8s
Related conjugates and formulations (1)
-
Anti-NMDAR2B antibody [EPR19295] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The NMDAR2B subunit contributes to the regulation of synaptic strength and is essential for processes involved in learning and memory. As part of the NMDA receptor complex it mediates excitatory neurotransmission and is involved in synaptic plasticity processes such as long-term potentiation (LTP). These functions are significant for cognitive function and neural development. The receptor's role in signal transduction is aided by the unique properties conferred by the NMDAR2B subunit such as its high affinity for glycine and slower deactivation kinetics.
Pathways
NMDAR2B is involved in the glutamatergic signaling pathway which is important for neural communication. It also participates in the calcium signaling pathway affecting cellular responses to external stimuli. The protein interacts with CaMKII and PSD-95 which are proteins that influence synaptic strength and architecture through these pathways. Its involvement links it to a variety of signaling events important for brain function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Publications (16)
Recent publications for all applications. Explore the full listand refine your search
Addiction neuroscience 15: PubMed40575352
2025
Applications
Unspecified application
Species
Unspecified reactive species
Research (Washington, D.C.) 7:0482 PubMed39301264
2024
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 30:e14632 PubMed38366763
2024
Applications
Unspecified application
Species
Unspecified reactive species
Physiological reports 11:e15673 PubMed37078449
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 25:104754 PubMed35938049
2022
Applications
Unspecified application
Species
Unspecified reactive species
The European journal of neuroscience 55:18-31 PubMed34902209
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in aging neuroscience 13:772980 PubMed34916926
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34830164
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neuroscience 15:641284 PubMed33994921
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2021:6634181 PubMed33833851
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com